导航

| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 7.12% | 1743/4982 |
| 近一周 | -1.89% | 3072/5417 |
| 近一月 | -5.64% | 4226/5423 |
| 近一季 | -3.22% | 1747/5376 |
| 近半年 | -3.53% | 2609/5131 |
| 近一年 | 3.44% | 2377/4741 |
| 近两年 | 49.90% | 2341/4208 |
| 近三年 | 16.26% | 2425/3661 |
| 成立以来 | 243.58% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
6.01% 569/5130 |
13.70% 2471/5464 |
- - |
- - |
| 2025 | 23.30% 2837/5130 |
3.12% 2477/4624 |
8.30% 613/4802 |
17.17% 3246/4970 |
-5.77% 3733/5130 |
| 2024 | -2.44% 2963/4618 |
-3.30% 2208/4340 |
-3.67% 2688/4442 |
7.03% 3282/4550 |
-2.15% 2170/4618 |
| 2023 | -23.49% 2999/4216 |
-1.47% 2680/3759 |
-7.68% 2929/3909 |
-7.53% 1944/4055 |
-9.03% 3584/4209 |
| 2022 | -12.75% 380/3578 |
-21.21% 2198/2804 |
12.95% 547/3205 |
-9.31% 874/3430 |
8.11% 341/3570 |
| 2021 | -8.31% 1344/2717 |
-2.49% 692/1745 |
14.35% 646/2232 |
-16.76% 2152/2560 |
-1.21% 1745/2708 |
| 2020 | 63.29% 385/1596 |
10.70% 55/1036 |
28.49% 324/1256 |
8.30% 808/1472 |
6.00% 1292/1690 |
| 2019 | 46.80% 289/926 |
22.80% 1142/3054 |
-0.05% 1377/3201 |
12.08% 148/939 |
6.71% 676/1014 |
| 2018 | -9.08% 18/668 |
- - |
- - |
- - |
-4.44% 1166/2977 |
| 2017 | 13.04% 256/531 |
- - |
- - |
- - |
- - |
| 2016 | -12.34% 190/455 |
- - |
- - |
- - |
- - |
| 2015 | 26.58% 323/433 |
- - |
- - |
- - |
- - |
| 2014 | 52.99% 25/432 |
- - |
- - |
- - |
- - |
| 2013 | 17.76% 155/398 |
- - |
- - |
- - |
- - |
| 2012 | 7.32% 147/459 |
- - |
- - |
- - |
- - |
| 2011 | -20.96% 122/392 |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商品质成长混合C | 1.0027 | 54.69% |
| 招商创新增长混合A | 1.0759 | 54.25% |
| 招商创新增长混合C | 1.0235 | 53.96% |
| 华泰柏瑞医疗健康A | 2.6422 | 49.29% |
| 华泰柏瑞医疗健康C | 2.5804 | 49.15% |
| 招商品质成长混合A | 1.0435 | 49.15% |
| 大摩优悦安和混合A | 0.8994 | 47.23% |
| 大摩优悦安和混合C | 0.8828 | 47.08% |
| 中信建投医药健康A | 0.7950 | 39.62% |
| 大摩健康产业混合A | 1.9440 | 32.70% |
| 诺安主题精选混合 VS. 长安宏观策略混合A(740001) |